National calendar of preventive vaccinations: present and future

Abstract

In the context of a pandemic of a new coronavirus infection, vaccine prophylaxis within the framework of the National Calendar of Preventive Vaccinations (NCPV) is an absolute priority in the fight against infectious diseases. The lecture presents the structure and features of the NCPV, the main directions of its improvement, information on the priority infections for vaccination. The strategy of immunization throughout life, which guarantees the creation of maximum protection against infections and preservation of the optimal level of health of people without age restrictions, is considered. Information is provided on approaches to vaccination of various patient populations against new coronavirus, pertussis, pneumococcal, and rotavirus infections. The presented lecture materials can be useful both to medical students and doctors of various specialties (infectious disease specialists, pediatricians, epidemiologists, bacteriologists).

Keywords:National calendar of preventive vaccinations; mandatory vaccination; priority infections; immunization strategy

Funding. The study had no sponsorship.

Conflict of interest. The authors declare no conflict of interest.

Contribution. Concept and design of the lecture – Kostinov M.P., Kharseeva G.G.; the collection and processing of the material – Kharseeva G.G., Chepusova A.V.; writing a text – Kharseeva G.G., Chepusova A.V.; editing – Kostinov M.P.

For citation: Kostinov M.P., Kharseeva G.G., Chepusova A.V. National calendar of preventive vaccinations: present and future. Infektsionnye bolezni: novosti, mneniya, obuchenie [Infectious Diseases: News, Opinions, Training]. 2022; 11 (2): 112–9. DOI: https://doi.org/10.33029/2305-3496-2022-11-2-112-119

References

1. United Nations, Department of Economic and Social Affairs, Population Division (2019). World Population Prospects 2019: Data Booket. URL: https://population.un.org/wpp/Publications/Files/WPP2019_DataBooklet.pdf (date of access November 16, 2021)

2. Namazova-Baranova L.S., Fedoseenko M.V., Baranov A.A. New horizons of the National calendar of preventive vaccinations. Voprosy sovremennoy pediatrii [Problems of Modern Pediatrics]. 2019; 18 (1): 13–30. DOI: https://doi.org/10.15690/vsp.v18i1.1988 (in Russian)

3. Strategy for the development of immunoprophylaxis of infectious diseases for the period up to 2035, Approved. by order of the Government of the Russian Federation of September 18, 2020 No. 2390-r. (in Russian)

4. The ideal calendar of preventive vaccinations for children, 2020. Pediatricheskaya farmakologiya [Pediatric Pharmacology]. 2019; 16 (6): 384–5. (in Russian)

5. Kostinov M.P., Maleev V.V. Hib infection: vaccine prevention issues. Moscow: Meditsina dlya vsekh, 1998: 78 p. (in Russian)

6. Baranov A.A., Namazova-Baranova L.S., Tatochenko V.K., et al. Vaccine prophylaxis of hemophilic infection type b in children. Eds by A.A. Baranov, L.S. Namazova-Baranova. Diseases of Childhood from A to Z: A guide for physicians. Issue 12. Moscow: Pediatr, 2016: 125–51. (in Russian)

7. Garashchenko T.I., Kostinov M.P., Il’enko L.I., et al. Preventive and therapeutic use of hemophilic and pneumococcal vaccines in frequently and long-term ill children with recurrent otitis media. Voprosy sovremennoy pediatrii [Problems of Modern Pediatrics]. 2006; 5 (5): 24–8. (in Russian)

8. Il’enko L.I., Kostinov M.P., Garashchenko M.V., et al. Immunization with vaccines for the prevention of pneumococcal, hemophilic infections and influenza in frequently and long-term ill children with chronic and often recurrent nonspecific infectious diseases of the bronchopulmonary system. Voprosy sovremennoy pediatrii [Problems of Modern Pediatrics]. 2006; 5 (4): 27–30. (in Russian)

9. Kostinov M.P. (ed.) Vaccination of adults – from strategy to tactics: a guide for doctors. Moscow: MDV, 2020: 248 p. ISBN 978-5-906748-17-1. (in Russian)

10. Baranov A.A., Briko N.I., Gorelov A.V., et al. Strategies for the control of chickenpox in Russia. Results of the International Meeting of the Expert Council on the Prevention of Chickenpox (W.A.V.E). Voprosy sovremennoy pediatrii [Problems of Modern Pediatrics]. 2010; 9 (3): 5–12. (in Russian)

11. Tarasova A.A., Kostinov M.P. The relevance of the use of a combined hexavalent vaccine against whooping cough, diphtheria, tetanus, hemophilic infection, poliomyelitis and hepatitis B. Farmateka [Pharmateca]. 2020; 27 (9): 92–8. DOI: https://doi.org/10.18565/pharmateca.2020.9.92-98 (in Russian)

12. Cherdantsev A.P., Kostinov M.P., Kusel’man A.I. Influenza vaccine prevention in pregnant women: a guide for doctors. Moscow: MDV, 2014: 112 p. (in Russian)

13. Cherdantsev A.P., Kostinov M.P., Kusel’man A.I. Vaccination of pregnant women against influenza and other infectious diseases: A guide for doctors. 3rd ed., suppl. Moscow: MDV, 2018: 143 p. (in Russian)

14. Vaccine prophylaxis of diseases caused by the human papillomavirus. Clinical guidelines, Moscow: Pediatr, 2017: 48 p. (in Russian)

15. Nikiforov V.V., Suranova T.G., Mironov A.Yu. New coronavirus infection (COVID-19): etiology, epidemiology, clinic, diagnosis, treatment and prevention: educational and methodological manual. Moscow: Akademiya postdiplomhogo obrazovaniya FMBA, 2020: 48 p. (in Russian)

16. Prevention, diagnosis and treatment of new coronavirus infection (COVID-19) Version 11: temporary guidelines (approved by the Ministry of Health of the Russian Federation on May 7, 2021). URL: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/055/735/original/BМР_COVID-19.pdf (date of access November 16, 2021) (in Russian)

17. Geers D., Shamier M.C., Bogers s., Hartog G.D., Gommers L., et al. SARS-CoV-2 variants of concern partially escape humoral but not T cell responses in COVID-19 convalescent donors and vaccine recipients. Sci Immunol. 2021; 6 (59): 7–14. DOI: https://doi.org/10.1126/sciimmunol.abj1750

18. Kostinov M.P., Markelova E.V., Svitich O.A., Polishchuk V.B. Immune mechanisms of SARS-CoV-2 and potential drugs for the prevention and treatment of COVID-19. Pul’monologiya [Pulmonology]. 2020; 30 (5): 700–8. DOI: https://doi.org/10.18093/0869-0189-2020-30-5-700-708 (in Russian)

19. Brentville V.A., Vankemmelbeke M., Metheringham R.L., Symonds P., Cook K.W., et al. A novel bivalent DNA vaccine encoding both spike protein receptor-binding domain and nucleocapsid protein of SARS-CoV-2 to elicit T cell and neutralising antibody responses that cross react with variants. bioRxiv. 2021; 6 (18): 448932. DOI: https://doi.org/10.1101/2021.06.18.448932

20. Verissimo C. De M., O’Brien C., López Corrales J., Dorey A., Cwiklinski K., et al. Improved diagnosis of SARS-CoV-2 by using nucleoprotein and spike protein fragment 2 in quantitative dual ELISA tests. Epidemiol Infect. 2021; 149: 1–28. DOI: https://doi.org/10.1017/S0950268821001308

21. Kostinov M.P., Svitich O.A., Markelova E.V. Potential COVID-19 immunization in high-risk groups: A temporary guide for doctors. Moscow: MVD, 2020: 64 p. ISBN: 978-5-906748-18-8. (in Russian)

22. Kostinov M.P., Chuchalin A.G. (eds) Priority vaccination of respiratory infections during the SARS-CoV-2 pandemic and after its completion: a guide for doctors. Moscow: MDV, 2020: 32 p. ISBN 976-5-906748-16-4. (in Russian)

23. Chuchalin A.G. (ed.) Respiratory medicine: A guide. 2nd ed. Vol. 2. Moscow: Litterra, 2017: 544 p. (in Russian)

24. Kostinov A.M., Kostinov M.P. Susceptibility to SARS-CoV-2 vaccinated against S. pneumoniae – mechanisms of nonspecific action of pneumococcal vaccine. Pediatriya. Zhurnal imeni G.N. Speranskogo [Pediatrics Journal named after G.N. Speransky]. 2020; 99 (6): 183–9. DOI: https://doi.org/10.24110/0031-403X2020-99-6-183-189 (in Russian)

25. Kostinov A.M., Kostinov M.P., Mashilov K.V. Pneumococcal vaccines and COVID-19 – antagonism. Meditsinskiy sovet [Medical Council]. 2020; (17): 66–73. DOI: https://doi.org/10.21518/2079-701X-2020-17-66-73 (in Russian)

26. Markelova E.V., Gushchina Y.S., Kostinov M.P., Zhuravleva N.V. Clinical and immunological effect of vaccination “PNEUMO 23” in children with atopic bronchial asthma. Zhurnal mikrobiologii, epidemiologii i immunobiologii [Journal of Microbiology, Epidemiology and Immunobiology]. 2005; (2): 83–5. (in Russian)

27. Kostinov M.P., Zverev V.V. (eds) Vaccination against hepatitis B, influenza and rubella in adult patients with chronic diseases: A guide. Moscow, 2009: 196 p. (in Russian)

28. Protasov A.D., Zhestkov A.V., Lavrent’eva N.E., et al. Effect of complex vaccination against pneumococcal, hemophilic type b infections and influenza in patients with chronic obstructive pulmonary disease. Zhurnal mikrobiologii, epidemiologii i immunobiologii [Journal of Microbiology, Epidemiology and Immunobiology]. 2011; (4): 80–4. (in Russian)

29. Ryzhov A.A., Kostinov M.P., Magarshak O.O. Application of vaccines against pneumococcal and hemophilic type b infections in persons with chronic pathology. Epidemiologiya i vaktsinoprofilaktika [Epidemiology and Vaccine Prophylaxis]. 2004; 19 (6): 24–7. (in Russian)

30. Nikiforov V.V., Orlova N.V., Suranova T.G., Mironov A. Yu., Polezhaeva N.A. Vaccinoprophylaxis of pneumococcal infection in conditions of continued spread of COVID-19. Epidemiologiya i infektsionnye bolezni [Epidemiology and Infectious Diseases]. 2020; 25 (2): 48–55. (in Russian)

31. Kostinov M.P. Fundamentals of immunorehabilitation for new coronavirus infection (COVID-19). A guide for doctors. Moscow: MDV, 2020: 112 p. ISBN 978-5-906748-06-5. (in Russian)

32. Kostinov M.P., Ababia I.I. (eds) Guidelines for vaccination and immunotherapy in ENT pathology. Moscow: MDV, 2019: 448 p. (in Russian)

33. Kostinov M.P. Immunocorrection of the vaccination process in persons with impaired health. Moscow: Meditsina dlya vsekh, 2006: 175 p. (in Russian)

34. Jenkins V.A., Savic M., Kandeil W. Pertussis in high-risk groups: an overview of the past quarter-century. Hum Vaccines Immunother. 2020; 16 (11): 2609–17. DOI: https://doi.org/10.1080/21645515.2020.1738168

35. Celentano L.P., Massari M., Paramatti D., Salmaso S., Tozzi A.E. Resurgence of pertussis in Europe. Pediatr Infect Dis J. 2005; 24: 761–5.

36. Pertussis (whooping cough). Signs and Symptoms. 2017. URL: https://www.cdc.gov/pertussis/about/signs-symptoms.html (date of access July 16, 2021)

37. Kostinov A.M., Kostinov M.P. Pertussis incidence and the effect of revaccination of preschool and school children. Infektsiya i immunitet [Infection and Immunity]. 2018; 8 (3): 284–94. (in Russian)

38. Kostinov M.P., Prutskova E.V., Cherdantsev A.P., et al. Safety of pertussis vaccines in adolescents. Zhurnal infektologii [Journal of Infectology]. 2020; 12 (4): 29–36. DOI: https://doi.org/10.22625/2072-6732-2020-12-4-29-36 (in Russian)

39. Cherdantsev A.P., Prutskova E.V., Kostinov M.P. New opportunities for vaccine prevention of whooping cough. Detskie infektsii [Children’s Infections]. 2020; 19 (2): 58–63. DOI: https://doi.org/10.22627/2072-8107-2020-19-2-58-63 (in Russian)

40. On the state of sanitary and epidemiological well-being of the population in the Russian Federation in 2019: State report. Moscow: Federal’naya sluzhba po nadzoru v sfere zashchity prav potrebiteley i blagopoluchiya cheloveka, 2020: 299 p. (in Russian)

41. Kostinov M.P., Chuchalin A.G. (eds) Guidelines for clinical immunology in respiratory medicine. 1st ed. Moscow: ATMO, 2016: 128 p. (in Russian)

42. Rogers M.A.M., Basu T., Kim C. Lower incidence rate of type 1 diabetes after receipt of the rotavirus vaccine in the United States, 2001–2017. Sci Rep. 2019; 9 (1): 7727. DOI: https://doi.org/10.1038/s41598-019-44193-4

43. Baranov A.A., Namazova-Baranova L.S., Tatochenko V.K., et al. Rotavirus infection in children is an unsolved problem. Review of recommendations for vaccine prevention. Pediatricheskaya farmakologiya [Pediatric Pharmacology]. 2017; 14 (4): 248–57. (in Russian)

44. Christensen H., May M., Bowen L., Hickman M., Trotter C.L. Meningococcal carriage by age: a systematic review and meta-analysis. Lancet Infect Dis. 2010; 10 (12): 853–61. DOI: https://doi.org/10.1016/s1473-3099(10)70251-6

45. Kostyukova N.N., Bekhalo V.A. Modern meningococcal vaccines and carrier of bacteria. Epidemiologiya i infektsionnye bolezni. Aktual’nye voprosy [Epidemiology and Infectious Diseases. Actual Issues]. 2019; 9 (2): 81–9. (in Russian)

46. Korovkina E.S., Kostinov M.P. Modern conjugate vaccines used for the prevention of meningococcal infection. Infektsionnye bolezni: novosti, mneniya, obuchenie [Infectious Diseases: News, Opinions, Training]. 2018; (1): 138–45. (in Russian)

CHIEF EDITOR
CHIEF EDITOR
Yushchuk Nikolay Dmitrievich
Academician of the Russian Academy of Sciences, Professor, head of the Infectious Diseases and Epidemiology Department, President of the Moscow State University of Medicine and Dentistry named after A.I. Evdokimov, Board member of the National Scientific Infectiologists? Society.
Вскрытие
Medicine today

II Всероссийская конференция с международным участием "Воспаление глаза" 12 ноября 2022 года, Москва Воспалительные заболевания глаза - широко распространенная и многогранная проблема, с которой может столкнуться в своей практике любой специалист. Найти оптимальные алгоритмы...

Масштабное событие в области дерматовенерологии и косметологии - II конференция InteDeCo 2022 "Интегративная дерматовенерология и косметология. Новые стандарты взаимодействия" - состоится 16-17 декабря 2022 года. Программа мероприятия пройдет на современной...

VIII Московский Городской Съезд педиатров с межрегиональным и международным участием "Трудный диагноз в педиатрии" Приглашаем педиатров, детских эндокринологов, реаниматологов, гинекологов, неонатологов, кардиологов, хирургов, урологов, психологов, специалистов по лучевой...


Journals of «GEOTAR-Media»